🔗 Share this article

Chancellor Reeves has stated she is planning "specific measures to address cost of living issues" in the upcoming Budget.

Speaking to media outlets, she emphasized that reducing price rises is a shared task of both the government and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the G7 developed nations this calendar year and the following year.

Potential Energy Cost Interventions

Reports indicate the government could intervene to reduce utility costs, such as by reducing the present 5% rate of VAT applied on energy.

Another approach is to cut some of the regulatory levies presently added to household expenses.

Budgetary Limitations and Analyst Expectations

The administration will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for these actions.

The expectation from the majority of experts is that Reeves will have to declare tax increases or spending cuts in order to meet her self-imposed borrowing rules.

Earlier on Thursday, estimates showed there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the more modest range of projections.

"It is a joint responsibility between the Bank of England and the administration to further reduce some of the sources of price increases," Reeves told reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the focus has been on expected tax rises, the chancellor said the latest data from the fiscal watchdog had not changed her commitment to manifesto promises not to raise rates on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with rising international and commercial issues for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

International Economic Tensions

Referring to apprehensions about the UK's trade ties with the Asian nation she said: "Our security interests always are paramount."

Recent statement by China to strengthen export controls on critical minerals and other materials that are key for high-technology production led US President the US President to threaten an further 100% tariff on imports from China, raising the risk of an all-out commercial conflict between the two global powers.

The US Treasury Secretary called China's decision "commercial pressure" and "a global supply chain control attempt."

Questioned on accepting the American proposal to participate in its battle with China, the Chancellor said she was "very concerned" by Chinese measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and causes additional challenges."

"I believe there are fields where we should address China, but there are also valuable chances to sell into Chinese markets, including financial services and other areas of the economy. We've got to achieve that balance correct."

The chancellor also confirmed she was cooperating with international partners "on our own critical minerals strategy, so that we are reduced dependence."

NHS Drug Costs and Funding

The Chancellor also admitted that the cost the National Health Service spends on pharmaceuticals could go up as a result of current negotiations with the US government and its drugs companies, in exchange for lower tariffs and investment.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or scrapping projects in the UK, with some attributing the modest returns they are obtaining.

Last month, the Science Minister said the cost the NHS spends on medicines would have to rise to prevent businesses and pharmaceutical investment departing from the UK.

The Chancellor told media: "It has been observed due to the cost structure, that clinical trials, innovative medicines have not been offered in the UK in the way that they are in other continental states."

"The objective is to ensure that individuals getting treatment from the National Health Service are can receive the best critical medicines in the world. And so we are looking at this situation, and... seeking to secure more investment into Britain."